POPULARITY
Categories
1,426 episodes with Conduct
1,420 episodes with Conduct
189 episodes with Conduct
159 episodes with Conduct
36 episodes with Conduct
33 episodes with Conduct
40 episodes with Conduct
77 episodes with Conduct
42 episodes with Conduct
30 episodes with Conduct
39 episodes with Conduct
63 episodes with Conduct
32 episodes with Conduct
24 episodes with Conduct
24 episodes with Conduct
41 episodes with Conduct
42 episodes with Conduct
23 episodes with Conduct
18 episodes with Conduct
41 episodes with Conduct
20 episodes with Conduct
19 episodes with Conduct
28 episodes with Conduct
22 episodes with Conduct
32 episodes with Conduct
17 episodes with Conduct
26 episodes with Conduct
18 episodes with Conduct
34 episodes with Conduct
8 episodes with Conduct
16 episodes with Conduct
24 episodes with Conduct
22 episodes with Conduct
17 episodes with Conduct
12 episodes with Conduct
12 episodes with Conduct
10 episodes with Conduct
6 episodes with Conduct
12 episodes with Conduct
12 episodes with Conduct
10 episodes with Conduct
6 episodes with Conduct
10 episodes with Conduct
8 episodes with Conduct
5 episodes with Conduct
31 episodes with Conduct
11 episodes with Conduct
9 episodes with Conduct
8 episodes with Conduct
7 episodes with Conduct
6 episodes with Conduct
8 episodes with Conduct
7 episodes with Conduct
7 episodes with Conduct
4 episodes with Conduct
14 episodes with Conduct
8 episodes with Conduct
6 episodes with Conduct
9 episodes with Conduct
8 episodes with Conduct
10 episodes with Conduct
16 episodes with Conduct
8 episodes with Conduct
7 episodes with Conduct
5 episodes with Conduct
20 episodes with Conduct
10 episodes with Conduct
11 episodes with Conduct
7 episodes with Conduct
5 episodes with Conduct
13 episodes with Conduct
3 episodes with Conduct
3 episodes with Conduct
6 episodes with Conduct
20 episodes with Conduct
8 episodes with Conduct
9 episodes with Conduct
12 episodes with Conduct
3 episodes with Conduct
7 episodes with Conduct
7 episodes with Conduct
10 episodes with Conduct
3 episodes with Conduct
7 episodes with Conduct
15 episodes with Conduct
5 episodes with Conduct
4 episodes with Conduct
6 episodes with Conduct
3 episodes with Conduct
5 episodes with Conduct
7 episodes with Conduct
5 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
4 episodes with Conduct
7 episodes with Conduct
5 episodes with Conduct
3 episodes with Conduct
7 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
4 episodes with Conduct
3 episodes with Conduct
10 episodes with Conduct
10 episodes with Conduct
2 episodes with Conduct
9 episodes with Conduct
14 episodes with Conduct
3 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
4 episodes with Conduct
7 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
5 episodes with Conduct
5 episodes with Conduct
7 episodes with Conduct
7 episodes with Conduct
7 episodes with Conduct
6 episodes with Conduct
3 episodes with Conduct
3 episodes with Conduct
6 episodes with Conduct
5 episodes with Conduct
3 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
5 episodes with Conduct
12 episodes with Conduct
4 episodes with Conduct
3 episodes with Conduct
3 episodes with Conduct
6 episodes with Conduct
5 episodes with Conduct
4 episodes with Conduct
3 episodes with Conduct
6 episodes with Conduct
4 episodes with Conduct
9 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
3 episodes with Conduct
3 episodes with Conduct
5 episodes with Conduct
5 episodes with Conduct
5 episodes with Conduct
2 episodes with Conduct
5 episodes with Conduct
8 episodes with Conduct
8 episodes with Conduct
8 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
6 episodes with Conduct
2 episodes with Conduct
4 episodes with Conduct
6 episodes with Conduct
4 episodes with Conduct
2 episodes with Conduct
3 episodes with Conduct
4 episodes with Conduct
4 episodes with Conduct
3 episodes with Conduct
5 episodes with Conduct
5 episodes with Conduct
3 episodes with Conduct
7 episodes with Conduct
76 episodes with Conduct
2 episodes with Conduct
3 episodes with Conduct
3 episodes with Conduct
4 episodes with Conduct
2 episodes with Conduct
The Daily Quiz - General Knowledge Today's Questions: Question 1: What type of structures are used to conduct a water stream across a valley? Question 2: What is the result of the mathematical operation obtained by subtracting the number of Snow White's dwarfs from the original title number of 'Disney Dalmatians'? Question 3: What word is used in the NATO Phonetic Alphabet for the letter T? Question 4: Which word is defined as 'a commotion or fuss'? Question 5: What is the total number of days in March, April, and May combined? Question 6: Which word is defined as 'of, pertaining to, or resembling a hedgehog'? Question 7: Which word is defined as 'a platform of a staircase where the stair turns back in exactly the reverse direction of the lower flight'? Question 8: Which word is defined as 'high-waisted skiing pants with shoulder straps'? Question 9: Which word is defined as 'to drink often; to eat and;or drink noisily'? This podcast is produced by Klassic Studios Learn more about your ad choices. Visit megaphone.fm/adchoices
A Federal judge has apologized after receiving a “private reprimand” for misconduct. The AP's Lisa Dwyer reports.
Wontumi–Samreboi Case: I am withdrawing from the case as counsel. I have informed my client, Chairman Wontumi, and the court. My reasons will be made known in court, but I believe there are too many unseen influences surrounding the case. I also find the judge's conduct throughout the proceedings unacceptable. — Andy Appiah-Kubi, Counsel for Bernard Antwi Boasiako.
In this special roundtable episode of Restorative Works!, host Claire de Mezerville López brings together a powerful group of restorative justice practitioners, educators, and leaders to explore the creation and impact of the Restorative Rainbow Alliance's Facilitator Code of Conduct. Guests Ames Stenson and Rami El Gharib, co-founders of the Restorative Rainbow Alliance, join Lindsey Pointer and Kathleen McGoey, co-authors of The Little Book of Restorative Teaching Tools, to share the story behind this groundbreaking initiative. Together, they reflect on the urgent need for LGBTQ+ affirming practices within restorative justice, drawing from lived experiences, community dialogue, and the gaps that led to harm when identity and power were not fully considered in restorative conferences. The conversation explores how the Alliance's Code of Conduct, now adopted as a foundational document in Colorado, offers both guidance and a call to reflection for practitioners seeking to move beyond cis-heteronormative frameworks and toward truly inclusive, equitable practice. The group also highlights a collaborative effort to bring the code to life through an engaging, experiential learning activity: Inclusive Facilitation: Increasing LGBTQ+ Awareness in Restorative Justice. Designed as a companion tool, this resource supports practitioners in navigating discomfort, building empathy, and applying inclusive principles to real-life scenarios through dialogue, play, and reflection. Throughout the episode, listeners are invited into a rich and honest conversation about harm, accountability, identity, and growth. The guests emphasize the importance of curiosity, compassion, and the willingness to sit with complexity as essential elements of restorative practices, especially when working toward belonging for LGBTQ+ communities. This episode offers both inspiration and practical pathways for anyone committed to deepening fostering spaces where all identities are affirmed and valued. Tune in to learn from these wonderful guests, and we invite you to explore the Restorative Teaching Tool activity for the Facilitator Code of Conduct here.
Ephesians Series: Ephesians 5:16b-The Reason Why the Believer Must Take Advantage of the Opportunity to Convict the Non-Believer with Their Godly Conduct-Lesson # 353
Ephesians Series: Ephesians 5:16b-The Reason Why the Believer Must Take Advantage of the Opportunity to Convict the Non-Believer with Their Godly Conduct-Lesson # 353
Noted Chicago attorney Christopher Parente, Partner, Cheronis & Parente, joins John Williams to talk about the release of the ‘Broadview Six' grand jury transcripts. Christopher tells John why this case still matters, the misconduct by the U.S. attorney’s office, and why the prosecutors kept on coming back to the grand jury to push the case.
Noted Chicago attorney Christopher Parente, Partner, Cheronis & Parente, joins John Williams to talk about the release of the ‘Broadview Six' grand jury transcripts. Christopher tells John why this case still matters, the misconduct by the U.S. attorney’s office, and why the prosecutors kept on coming back to the grand jury to push the case.
Noted Chicago attorney Christopher Parente, Partner, Cheronis & Parente, joins John Williams to talk about the release of the ‘Broadview Six' grand jury transcripts. Christopher tells John why this case still matters, the misconduct by the U.S. attorney’s office, and why the prosecutors kept on coming back to the grand jury to push the case.
With uneven growth and slowing productivity in many regions, can growth still be inclusive, sustainable and create decent jobs? This discussion looks at how responsible business practices shape firms, treatment of workers and the wider economy. Podcast guests: Mark Birrell, President, Australian Chamber of Commerce and Industry (ACCI) Abdul-Moomin Gbana, General Secretary, Ghana Mine Workers Union Githa Roelans, Head of the Multinational Enterprises and Responsible Business Conduct Unit, ILO
Congressional hearings, whistleblower allegations, and the release of new government records in recent weeks have continued to fuel public questions of whether long-hidden information about UFOs may finally be coming to light. And part of that fascination also extends to Hollywood, with the forthcoming release of Steven Spielberg's film Disclosure Day, which early reviews have called one of the Close Encounters of the Third Kind director's best films in decades. This week on The Micah Hanks Program, we look at the possibility of a real-life "Disclosure Day," and how a scientific committee long involved in the serious search for evidence of intelligent life on other worlds is working on establishing new protocols for how final proof of alien life should be revealed to the public if we find them. Want to advertise/sponsor The Micah Hanks Program? We have partnered with the AdvertiseCast to handle our advertising/sponsorship requests. If you would like to advertise with The Micah Hanks Program, all you have to do is click the link below to get started: AdvertiseCast: Advertise with The Micah Hanks Program Show Notes Below are links to stories and other content featured in this episode: BRAZIL UAP: Everything we know about the UFO Sighting in Brazil on May 31, 2026 DISCLOSURE DAY: Director Steven Spielberg on aliens: "I absolutely think that they have been here" CONSPIRACY: Steven Spielberg rejects Disclosure Day alien conspiracy theories SETI: Position Paper on Declaration of Principles Concerning the Conduct of the SETI ALIEN TECH: SETI Institute Looks for Signs of Technology in Interstellar Visitor 3I/ATLAS BECOME AN X SUBSCRIBER AND GET EVEN MORE GREAT PODCASTS AND MONTHLY SPECIALS FROM MICAH HANKS. Sign up today and get access to the entire back catalog of The Micah Hanks Program, as well as "classic" episodes, weekly "additional editions" of the subscriber-only X Podcast, the monthly Enigmas specials, and much more. Like us on Facebook Follow @MicahHanks on X. Keep up with Micah and his work at micahhanks.com.
Marc Munden takes hosts Josh Olson and Joe Dante through the movies that inspired him while directing the new LORD OF THE FLIES miniseries. Show Notes: Movies Referenced In This Episode Lord of the Flies (1963) Lord of the Flies (1990) If… (1968) - 12:04 Britannia Hospital (1982) O Lucky Man! (1973) A Clockwork Orange (1971) Walkabout (1973) Picnic at Hanging Rock (1975) Monos (2019) Under The Skin (2013) Jackie (2016) Johnny Mad Dog (2008) The 400 Blows (1959) Zero for Conduct (1933) Rock ‘n' Roll High School (1979) Come and See (1985) Apocalypse Now (1979) The Tribe (2014) Other Notable Items Our Patreon! The Hollywood Food Coalition Utopia TV series (2013-14) Lord of the Flies limited series (2026) BritBox Netflix House of Pies in Los Angeles Jack Thorne Lord of the Flies novel by William Golding (1954) Peter Brook Richard Mosse Lindsay Anderson Malcolm McDowell Francois Truffaut Jean-Pierre Léaud Graham Crowden Peter Jeffrey Mona Washbourne Stanley Kubrick Nicholas Roeg Jenny Agutter Luke Roeg John Barry Peter Weir Alejandro Landes Mica Levi Jean-Stéphane Sauvaire Jean Vigo Charlie Chaplin Rome TV series (2005-07) HBO Elem Klimov Francisco Goya Aleksei Kravchenko Olga Mironova Roger Deakins Heart of Darkness novella by Joseph Conrad (1899) Learn more about your ad choices. Visit megaphone.fm/adchoices
Fire Conference 2026 Session #3
This is such an important conversation on how to raise our teens with agency so that they have the skills to set boundaries, and know what they want and know what they don't want. This conversation about consent explores all the nuances of a true consent. We address what moms can do to reduce the shame factor so our teens will be honest with us. Dr. Laura McGuire is an internationally recognized consultant, survivor, researcher, seminarian, and author of the book Creating Cultures of Consent (Rowman & Littlefield, 2021) and The Sexual Misconduct Prevention Guidebook: Consent and Conduct for Higher Education Campuses (Fielding University Press, 2022). They were named as one of the 2022 Champions of Pride by the Advocate Magazine and are regularly featured in media outlets for their expertise and approachability. Dr McGuire is a certified member of the American Association of Sexuality Educators Counselors and Therapists (AASECT), and The Society of Professional Consultants. Dr. McGuire lives in the United States, where she works as an adjunct professor at Widener & Dominican University and CEO at The National Center for Equity and Agency. To learn more and contact Laura: https://equityandagency.com/ https://drlauramcguire.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices
The Aaron Spencer murder case is over. A judge killed it. And the language in his order reads like the opening chapter of a federal investigation that hasn't started yet. Judge Ralph Wilson Jr. found that law enforcement's handling of evidence showed "a pattern of policy and procedure violations" and gave "the appearance of a coverup." Conduct so egregious that dismissal — the most extreme remedy available — was the only option.Spencer found his thirteen-year-old daughter in the truck of Michael Fosler after midnight. Fosler had over forty criminal counts pending involving that child and was out on bond with a no-contact order. Spencer acted. Called 911. And the state of Arkansas charged him with murder. Then the investigation started falling apart — or, depending on how you read the judge's order, started working exactly as someone intended.The dashcam SD card from Fosler's truck — the one piece of evidence that could have shown those critical final moments — was handled in violation of department policy and then vanished from the evidence chain. The department responsible was led by the sheriff Spencer was running against. The original judge was removed by the Arkansas Supreme Court after attempting to silence the defendant and restrict public access. State legislators flagged concerns about the fairness of the process. The prosecutor opposed dismissal in his final filing the day before Wilson granted it.Spencer won the Republican primary for sheriff with over fifty-three percent of the vote while under indictment for murder. The voters made their judgment. Now a judge has made his. But nobody in an official capacity has asked the question underneath all of this: if every part of Lonoke County's system was willing to move against a father who protected his child, what were they protecting? And who else does that trail lead to?Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/ Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1 Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#AaronSpencer #LonokeCounty #TrueCrime #HiddenKillers #CaseDismissed #Coverup #Arkansas #EvidenceTampering #JusticeSystem #FBI
What if the thing affecting your marriage the most is not what you're saying… but how you're showing up?In this episode of the Pursue HER Podcast, Kelley unpacks the power of a wife's conduct through the lens of The Holy Bible and why our actions often carry more weight than our words. This conversation is not about being silent, weak, or pretending everything is okay. It is about becoming so confident in who you are as a daughter of God that your peace, wisdom, consistency, and emotional maturity begin to shift the atmosphere of your marriage.If you've been feeling frustrated, emotionally disconnected, constantly repeating yourself, or trying to carry your marriage on your own, this episode will encourage and challenge you. Marriage is not a sprint. It is a marathon. And sometimes transformation starts with the conduct of a wife who is anchored in God.
When the pandemic hit, the instruction was simple: "Go home." But returning to a hybrid model? That's a complex, messy experiment full of grey areas. In this episode from the archive, Andy Lopata chats to human potential expert Nikki Bush, dialing in from Johannesburg. They explore why the return to hybrid work is causing so much stress for both leaders and teams, and why standardising rules across an entire organisation often leads to disaster. Nikki shares practical strategies for navigating this new autonomy, emphasising the need for employees to act as "intrapreneurs." Discover why the number one hybrid trap is "meeting-itis," how to ensure your virtual one-on-ones aren't just tick-box exercises, and the profound difference a leader can make by truly seeing the essence of their team members beyond their job descriptions. If you're struggling to balance flexibility with productivity, this episode offers a roadmap for connection. What you will learn in this episode The Autonomy Shift: Why hybrid work requires employees to stop acting like traditional staff and start thinking like "intrapreneurs" who are solely responsible for their output. The Illusion of Choice: Why giving employees too much choice in a hybrid model actually increases stress, and how to find the right balance of structure. The "Meeting-itis" Trap: Why over-scheduling meetings is the biggest mistake hybrid leaders make, and how it actively prevents real work from getting done. Beyond the Job Description: How to uncover the hidden "essence" of your team members. The Power of Intentional Listening: Why the success of your one-on-ones depends entirely on your intent, and how to prove you are listening with your "whole being." Actionable Insights Decentralise Hybrid Mandates: Do not try to mandate a single hybrid schedule (e.g., "everyone is in on Tuesdays") for an entire organisation. Empower individual team leaders to create their own bespoke hybrid mandates based on the specific operational needs and cross-departmental requirements of their group. Visibly Protect "Sacred Time": When conducting a one-on-one (especially virtually), explicitly state that you are turning off your devices to be fully present. If you must leave your phone on for an emergency, set that expectation at the very beginning of the meeting. This verbal boundary demonstrates profound respect. Conduct an "Essence Audit": Look past your team's job titles. Identify their innate strengths—who is the nurturer? Who brings levity during a crisis? Actively share these observations with them. Reflecting these strengths back to your team not only builds confidence but allows you to deploy them more effectively when unforeseen challenges arise. SELECTED LINKS FROM THE EPISODE Connect with Andy Lopata: Website | Instagram | LinkedIn | X/Twitter | YouTube Connect with Nikki Bush: Website |Instagram | The Financial Times Guide to Mentoring Episode 172 Featuring Nikki Bush
We recorded live from the SAP AI Intelligence Event hosted at the stunning Booking.com HQ in Amsterdam — a 3-day community-driven event that brought together SAP developers, AI practitioners, academics, and developer advocates from across Europe and beyond.Here's a taste of what we covered:AI Voice Agents in Healthcare — Ronald van der Looij (Versaia) shared how they're building AI agents to proactively manage medication reviews for elderly patients and reduce costly no-shows in mental health care. The ROI is real: one missed mental health appointment = €600 lost.The 4 Layers of AI — Evelien van der Hurk (CGI / former TU Denmark) broke down descriptive, diagnostic, predictive, and prescriptive analytics — and why the last one could unlock 20%+ savings for enterprises. Plus a sharp warning on AI bias that had the room talking.APM for ABAP — Marc Bernard introduced apm.to, a package manager for ABAP developers. Think NPM, but for SAP. Live in weeks. ABAP is not dead!SAP Developer Advocates — A brilliant panel on when AI actually makes sense (spoiler: not everywhere), the future of SaaS, and how to avoid getting lost in the hype.The big takeaway? AI is not the solution for everything — but knowing WHERE it adds real value is the skill that matters now.Huge thanks to Robert Eijpe for organizing this incredible event, and to Booking.com, Eswelt, Conduct, SAP, Lemongrass, AWS, and NL4B for making it possible.Chapters00:00:00 Intro00:01:12 Event setup with Robert Eijpe00:12:07 Agents working with agents and saving money with Ronald van der Looij00:24:02 4 layers of AI with Evelien van der Hurk00:42:43 APM for ABAP with Marc Bernard00:50:26 Round table with SAP Developer Advocates Nora, Kevin and Vitaliy and SAP Community Advocate Anne01:04:44 Wrap up
Mature Conduct In the Christian life, one of the easiest traps to fall into is thinking we have already arrived. Some believers think maturity means they have reached a point where they no longer need correction. Others think maturity means they already understand everything important about the Christian…
Josh (@cardboard_chronicles) and Chris (@chris_hoj), the founders of Card Ladder, join forces to bring you the most entertaining and educational sports card discussion on the internet every Friday night.Conduct your own Card research like the pro's with Card Ladder. Go to http://www.cardladder.com and browse thousands of cards for free and you can unlock more great features by going pro for $15/month (with a 7-day free trial).Follow Card Ladder @CardLadder on instagram here: https://www.instagram.com/cardladder/Follow Josh @Carboard_Chronicles on instagram here: https://www.instagram.com/cardboard_chronicles/Follow Chris @Chris_HOJ on instagram here: https://www.instagram.com/chris_hoj/Follow Kristina @KristinasPC on instagram here: https://www.instagram.com/kristinaspc/Follow Stiff @StiffArmWax on instagram here: https://www.instagram.com/stiffarmwax/
Send us Fan Mail Structural Engineer Career in India: Salary, Scope, Colleges & Future Opportunities What keeps a skyscraper standing during strong winds?How does a bridge safely carry thousands of vehicles every day?And what ensures that hospitals, schools, airports, and metro stations remain safe for decades?The answer lies in the work of a Structural Engineer. In this episode of The Kapeel Gupta Career PodShow, we explore one of the most respected and impactful engineering careers in the world.Structural Engineering is where mathematics, physics, design, safety, and innovation come together to create the infrastructure that powers modern civilization.If you are a student who enjoys problem-solving, engineering, construction, design, and real-world applications of science, this episode could open the door to a highly rewarding career.
Mackenzie Shirilla has accumulated thirty-six conduct violations at the Ohio Reformatory for Women since her August 2023 conviction — guilty findings on thirty-two. Her institutional file includes unauthorized medication, contraband, altered clothing, refusal of work assignments, and more than a hundred video visits with an unapproved released former inmate conducted under a false identity. Defense attorney and former prosecutor Eric Faddis examines what this record means for her September 2037 parole eligibility.Shirilla was convicted of killing Dominic Russo and Davion Flanagan after driving her vehicle into a brick building at approximately a hundred miles an hour in Strongsville, Ohio, in July 2022. She is serving two concurrent sentences of fifteen years to life.Recorded calls obtained from the institution reveal Shirilla referring to herself as the third victim, rejecting rehabilitation programs, and discussing plans to become a life coach after release. On calls she is aware are monitored, she has made statements about the town of Strongsville and expressed no acknowledgment of responsibility for the deaths of Russo and Flanagan.Faddis provides analysis of how parole boards assess institutional conduct, what weight individual violations carry in a hearing, and whether an inmate's refusal to engage with rehabilitative programming affects the board's calculus. He also addresses whether recorded statements made on monitored prison calls can be introduced and weighed against the inmate at a future parole proceeding.Join Our SubStack For AD-FREE ADVANCE EPISODES & EXTRAS!: https://hiddenkillers.substack.com/Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/channel/UC8-vxmbhTxxG10sO1izODJg?sub_confirmation=1Instagram https://www.instagram.com/hiddenkillerspod/Facebook https://www.facebook.com/hiddenkillerspod/Tik-Tok https://www.tiktok.com/@hiddenkillerspodX Twitter https://x.com/TrueCrimePodThis publication contains commentary and opinion based on publicly available information. All individuals are presumed innocent until proven guilty in a court of law. Nothing published here should be taken as a statement of fact, health or legal advice.#MackenzieShirilla #ShirillaParole #TheCrashNetflix #DominicRusso #DavionFlanagan #TrueCrime #EricFaddis #TrueCrimeToday #OhioReformatory #ParoleBoard
On this Salcedo Storm Podcast:Kristi Leigh is an award-winning former mainstream news anchor with more than 20 years in broadcasting. She won the Ohio Associated Press Best Anchor award before taking a lead anchor role in California, then walked away from her successful legacy media career to report independently in the fight for accountability and truth — and you can now find her daily on Lindell TV with DC Dispatch and her weekly long-form show “Get Free with Kristi Leigh.”
Send us Fan MailFood Technologist Career in India: Salary, Scope, Colleges & Future OpportunitiesHave you ever wondered who ensures that your favourite chips, yogurt, protein bar, packaged juice, or healthy snack is safe, nutritious, tasty, and has a long shelf life?Behind every successful food product is a professional who combines science, innovation, safety, and consumer understanding.
🧭 REBEL Rundown 🔑 Key Points 🧩 Human Factors: The unseen behaviors, distractions and considerations critical in emergency medicine and the ICU, influencing patient care beyond just medical knowledge.🎯 System Design: Effective system design directly impacts team performance by creating environments that facilitate optimal decision-making. 🏥 Real-world Application: The application of human factors in healthcare leads to better team dynamics, reduced stress, and improved patient outcomes. 👷🏽️It’s Everyone’s Job: Building a culture of adaptability and openness to change can lead to better healthcare delivery, communication and interprofessional relationships🛠️ Practical Solutions: Start the conversation in departments for actionable and pragmatic changes to current healthcare environments to enhance practitioner efficiency and patient care quality. Click here for Direct Download of the Podcast. 👀Previously Covered and Related Content: REBEL EM: Titles Don’t Make LeadersREBEL MIND: Moving from Junior to Senior Leadership in Emergency CareREBEL MIND: The Dunning-Kruger EffectREBEL MIND: Growth vs Fixed Mindset 📝 Introduction Welcome back to Rebel MIND, the podcast where we sharpen the person behind the practitioner. MIND stands for Mastering Internal Negativity during Difficulty. This series emphasizes productivity, provider performance, and team optimization to ensure we are at our best during high-pressure situations. In this episode, host Dr. Mark Ramzy chats with special guests and master educators about the concept of human factors.Dr. Chris Hicks is an emergency physician and trauma team leader at St. Michael’s Hospital in Toronto, Assistant Professor in the Department of Medicine at the University of Toronto, and co-founder of Advanced Performance Healthcare Design, a physician-led simulation and design group. Dr. Andrew Petrosoniak is an emergency physician and trauma team leader at St. Michael’s Hospital, and Medical Director of the Unity Health Toronto Simulation Program. He’s an Assistant Professor at the University of Toronto where his research focuses on simulation for systems and design improvement and optimizing the care of the bleeding patient. Along with Dr. Hicks, he’s also President of Advanced Performance Healthcare Design, a consulting firm that works with high-performance teams and uses simulation to enhance and design better healthcare spaces Cognitive Question How can the integration of human factors improve decision-making and performance in emergency medicine and critical care environments? ️What are Human Factors? In the context of healthcare, human factors encompass the interplay between humans, the systems they work within, and the effectiveness of their interactions. It includes elements like communication, system design, environmental conditions, and behavioral patterns affecting individual and team decision-making processes. It’s the collective impact of individual behaviors, team dynamics, and the physical environment on performance and outcomes. The aim is to eliminate issues arising from human error by creating systems and environments that naturally guide and support optimal performance. 🏥How This Applies to the Emergency Department or ICU? Efficient integration of human factors in high-pressure settings like the Emergency Department (ED) or Intensive Care Unit (ICU) helps mitigate the risks associated with stressful and chaotic environments. By focusing on system designs that account for human behavior, healthcare professionals can reduce errors, enhance team coordination, and ultimately improve patient care. This is crucial as teams are often required to make rapid, life-saving decisions in these environmentsThe design of clinical spaces can either hinder or help efficient care. Poorly arranged equipment or cluttered workspaces increase stress and impede decision-making. Implementing structured design principles, such as dedicated equipment zones and clear visual cues, can streamline workflows and enhance team coordinationIt actually helps pave the way for more efficiency because you end up “working smarter instead of harder”.It speaks directly to the Daniel Kahneman’s theory of Type 2 Thinking – which is a slow, analytical cognitive process requiring deliberate thoughtWe’ll likely create a whole dedicated episode to this but if you want to read more ahead of time on it, check out his book Thinking, Fast and Slow ⏩Immediate Action Steps for Your Next Shift **Assess Your Environment**: Take note of any clutter, noise, or layout issues in your workspace that could hinder optimal performance. Identify problem areas that could be optimized.**Recognizable Hard-Stop** – Implement a “Stop-Point” Check for areas or issues that involve more than just patient safety (ie. workflow inefficiencies, sign-out, throughput, etc). Use predefined benchmarks during procedures to ensure clarity and efficiency.**Foster Open Communication** – Encourage an environment where every team member feels comfortable discussing their thoughts and decisions without fear of judgment.**Prototype Solutions** – Work with colleagues to identify problems and brainstorm quick, cost-effective solutions that could be tested in your department.**Role Clarity and Preparation** – Ensure roles are clearly defined and team members are prepared with necessary resources readily available during high-stakes scenarios.**Test and Refine** – Conduct quick pilot tests of new setups or processes during quieter times and gather feedback from your team. Conclusion Human factors play a critical role in shaping healthcare outcomes. Through structured system designs and attention to team dynamics, it is possible to reduce inefficiencies and enhance both patient care and provider well-being. It requires a shift in perspective from seeing design and systems as separate from human behaviors, to seeing them as intricately linked. By incorporating these principles, healthcare professionals can create environments that inherently support better, safer, and more effective patient care. 🚨 Clinical Bottom Line Incorporating human factors into healthcare isn’t just about preventing errors—it’s about creating an ecosystem where the healthcare team is empowered to perform at their best, even under the most challenging conditions. Implementing small, iterative changes can create a meaningful impact, paving the way for improved systems and processes. This starts by redesigning systems and environments with human factors in mind, which can significantly improve both the efficiency of care delivery and the safety of the healthcare environment. Further Reading Petrosoniak A, Hicks C. M&M rounds 2.0: the future of performance improvement. CJEM. Feb 2025PMID: 39979684Petrosoniak A, Hicks CDesign, build, train, excel: Using simulation to create elite trauma systems. International Anesthesiology Clinics. Publish Ahead of Print.Request the Article herePetrosoniak A, Hicks C, et al. Design Thinking-Informed Simulation: An Innovative Framework to Test, Evaluate, and Modify New Clinical Infrastructure. Simul Healthc. 2020 Jun 2020.PMID: 32039946Bleetman A, et al.Human factors and error prevention in emergency medicine. Emerg Med J. May 2012PMID: 21565880Hayden EM, et al.Human Factors and Simulation in Emergency Medicine. Acad Emerg Med. 2018 Feb 2018PMID: 28925571 Meet the Authors Mark Ramzy, DO Co-Editor-in-Chief Cardiothoracic Intensivist and EM Attending RWJBH / Rutgers Health, Newark, NJ Chris Hicks, MD, Med Co-Founder of Advanced Performance Assistant Professor of Emergency Medicine, University of Toronto, Canada Andrew Petrosoniak, MD, MSc Co-Founder and President of Advanced Performance Medical Director of Unity Health Toronto Simulation Program Showing Slide 1 of 3 The post REBEL MIND – Human Factors: The Hidden Architecture of Emergency & Critical Care Medicine appeared first on REBEL EM - Emergency Medicine Blog.
Pastor Jeremy challenges the idea that holiness is restrictive; in fact, holiness is one of the keys to living in true freedom! While culture tells us to do whatever feels good, God's way leads to a deeper joy that this world can never provide. The good news is that we don't pursue holiness on our own—God's grace and the power of the Holy Spirit help us become more like Jesus every step of the way.
Pastor Jeremy challenges the idea that holiness is restrictive; in fact, holiness is one of the keys to living in true freedom! While culture tells us to do whatever feels good, God's way leads to a deeper joy that this world can never provide. The good news is that we don't pursue holiness on our own—God's grace and the power of the Holy Spirit help us become more like Jesus every step of the way.
Espionage isn't just about microchips and safehouses; it's about surviving the brutal wilderness to watch an adversary unawares. Clark Impastato breaks down the grueling realities of long-range reconnaissance patrols (LRRPs) designed to intercept enemy communications and movements. Discover the patience, technology, and sheer endurance needed to gather critical intelligence from the shadows.
https://expatmoney.com/antiwarPhone bank for Defend the Guard: https://defendtheguard.us/phonebankSign up for our newsletter: https://www.antiwar.com/newsletter/
See omnystudio.com/listener for privacy information.
See omnystudio.com/listener for privacy information.
Beyond the Pearls: Cases for Med School, Residency and Beyond (An InsideTheBoards Podcast)
Today's Case A 10-year-old boy presents to the clinic with his parents. They describe how he refuses to accept adult authority. He is easily annoyed and often loses his temper over small disappointments. The boy has already been suspended from school after hitting a teacher who was trying to restrain him when he refused to take a test and then ran out of the classroom and toward a busy street. Today's Reader Taylor Scott is a fourth-year Honours Biology student at the University of Victoria. About Dr. Raj Dr Raj is a quadruple board certified physician and associate professor at the University of Southern California. He was a co-host on the TNT series Chasing the Cure with Ann Curry, a regular on the TV Show The Doctors for the past 7 seasons and has a weekly medical segment on ABC news Los Angeles. More from Dr. Raj The Dr. Raj Podcast Dr. Raj on Twitter Dr. Raj on Instagram Want more board review content? USMLE Step 1 Ad-Free Bundle Crush Step 1 Step 2 Secrets Beyond the Pearls The Dr. Raj Podcast Beyond the Pearls Premium USMLE Step 3 Review MedPrepTGo Step 1 Questions MedPrepTGo Step 2 Questions Learn more about your ad choices. Visit megaphone.fm/adchoices
This week on The Food Professor Podcast, recorded live at SIAL Canada 2026 in Montreal, Michael LeBlanc and Dr. Sylvain Charlebois welcome back Karen Proud, President & Adjudicator of the Canada Grocery Code, for an important conversation about one of the most closely watched structural reforms in the Canadian grocery industry. Only months after the official launch of the Canada Grocery Code, Proud provides an inside look at how the new voluntary, industry-led framework is functioning in its early stages. She explains the mission of the Office of the Grocery Sector Code of Conduct, the rationale behind creating a voluntary code instead of government regulation, and why more than 200 companies have already joined the initiative. Proud discusses how the code is designed to improve business relationships between retailers and suppliers, strengthen transparency, create more predictable contracting practices, and encourage long-term investment and innovation throughout Canada's food supply chain. The conversation explores the challenges of building trust across a fragmented grocery ecosystem while balancing supplier concerns, retailer expectations, and government scrutiny. Proud outlines how her office is approaching compliance, dispute resolution, reporting transparency, and stakeholder engagement while emphasizing that the code is not intended to directly control grocery prices or solve food inflation. Instead, the long-term objective is to create a healthier and more competitive grocery marketplace that ultimately benefits Canadian consumers through increased investment, innovation, and product diversity. Before the interview, Michael and Sylvain dive deep into the rapidly rising price of chicken in Canada, examining how supply management, quota allocation challenges, and surging consumer demand are contributing to record levels of poultry imports from the United States and beyond. They debate whether the current system is adequately responding to shifting protein demand as consumers move away from expensive beef toward chicken. The episode also explores Quebec's decision to permanently remove sales tax from certain grocery categories, growing concerns among Canadian beef producers over potential trade negotiations involving South American imports, and how global instability, drought conditions, and disruptions around the Strait of Hormuz are beginning to impact grain and wheat prices worldwide. About UsDr. Sylvain Charlebois is a Visiting Professor in Food Policy and Distribution at McGill University and a Professor in Food Distribution and Policy in the Faculty of Management at Dalhousie University in Halifax. He is also the Senior Director of the Agri-food Analytics Lab, also located at Dalhousie University.Known as “The Food Professor”, his current research interest lies in the broad area of food distribution, security and safety. He is one of the world's most cited scholars in food supply chain management, food value chains and traceability with over 775 published peer-reviewed journal articles. Dr. Charlebois is also an editor for the prestigious Trends in Food Science Technology journal. He co-hosts The Food Professor podcast, discussing issues in the food, foodservice, grocery and restaurant industries and which is the most listened Canadian management podcast in Canada. Every year since 2012, he has published the now highly anticipated Canadian Food Price Report, which provides an overview of food price trends for the coming year. Furthermore, his research has been featured in several newspapers and media groups, nationally as well as internationally. He has testified on several occasions before parliamentary committees on food policy-related issues as an expert witness. He has been asked to act as an advisor on food and agricultural policies in many Canadian provinces and other countries.With extensive experience collaborating with businesses, governments, and NGOs, Dr. Charlebois combines academic rigor with practical expertise, making him one of the most influential voices in the global agri-food landscape. His work continues to advance the understanding of food systems, fostering innovation and resilience in a rapidly evolving industry. In 2025, he received the prestigious Charles III medal recognizing his tremendous work in informing Canadians about food issues. Michael LeBlanc is a senior retail advisor, keynote speaker and media entrepreneur. Michael has delivered keynotes, hosted fire-side discussions hosted senior retail executive on-stage in 1:1 interviews worldwide. Michael produces and hosts a network of leading retail trade podcasts, including The Remarkable Retail Podcast, The Voice of Retail, The Food Professor, The FEED powered by Loblaw and the Global eCommerce Leaders podcast. He has been recognized by the National Retail Federation (NRF) as a global Top Retail Voice for 2025 and 2025, and continues to be a ReThink Retail Top Retail Expert for the fifth year in a row.
Kiliii Yuyan – Guardians of Life: How Indigenous Peoples Are the World's Best Conservationists A deep‑dive into the 10 Frames Per Second podcast episode with Kiliii Yuyan
Date: Sunday, May 27th, 2026Speaker: Pastor Greg Hill Scripture: Deuteronomy 12:1-32
Implementing a clear progressive discipline policy ensures that your organization handles employee performance issues fairly and legally. This episode covers this essential HR topic which I have avoided for over 5 years.
Building on the concepts introduced in the previous episode Rethinking the Design and Conduct of Kidney Trials, this episode explores how innovative ideas in nephrology research can be translated into practical trial strategies. Experts discuss novel approaches to trial design, evolving endpoint selection, and the importance of engaging patients, clinicians, regulators, and other stakeholders throughout the research process. Drawing on insights from the ISN Consensus Meeting on Changing Paradigms of Studies in CKD (Vancouver, Nov 22-23, 2024), the discussion highlights how more pragmatic and implementation-focused trials can help generate evidence that is meaningful for clinical practice and patient care worldwide. Speakers Adeera Levin Professor of Medicine, University of British Columbia, Canada, and Past-President of the International Society of Nephrology (ISN). Dr. Levin is a global leader in kidney health research, with extensive experience in chronic kidney disease (CKD) management, clinical trials, and international health system strengthening. David Wheeler Professor of Kidney Medicine at University College London, UK and Honorary Consultant Nephrologist at the Royal Free Hospital. His research focuses on the management of chronic kidney disease and the evaluation of therapies through large-scale clinical trials. He was co-principal investigator of the landmark DAPA-CKD trial and served as Co-Chair of KDIGO from 2012–2019. Kevin Weinfurt Professor and Vice Chair of Faculty, Department of Population Health Sciences, Duke University School of Medicine, USA. Dr. Weinfurt is a behavioural scientist specializing in patient-reported outcomes (PROMs), ethical aspects of research participation, and improving the relevance of clinical trials to patients lived experiences. Hiddo J. Lambers Heerspink Professor of Clinical Trials and Personalized Medicine, University Medical Center Groningen, The Netherlands. Dr. Heerspink's work bridges pharmacology, nephrology, and precision medicine, focusing on optimizing kidney and cardiovascular outcomes through innovative clinical trial design and biomarker discovery. To read more, explore the related paper Changing Paradigms of Studies in Kidney Diseases published in Kidney International.
In this message from Philippians 1:27–28, we're challenged to live lives that truly reflect the gospel of Jesus Christ. As believers, we're called to stand firm in one spirit, strive together in unity, and boldly contend for the faith with courage and conviction. Be encouraged to live out your faith daily and strengthen one another as the body of Christ.
Josh (@cardboard_chronicles) and Chris (@chris_hoj), the founders of Card Ladder, join forces to bring you the most entertaining and educational sports card discussion on the internet every Friday night.Conduct your own Card research like the pro's with Card Ladder. Go to http://www.cardladder.com and browse thousands of cards for free and you can unlock more great features by going pro for $15/month (with a 7-day free trial).Follow Card Ladder @CardLadder on instagram here: https://www.instagram.com/cardladder/Follow Josh @Carboard_Chronicles on instagram here: https://www.instagram.com/cardboard_chronicles/Follow Chris @Chris_HOJ on instagram here: https://www.instagram.com/chris_hoj/Follow Kristina @KristinasPC on instagram here: https://www.instagram.com/kristinaspc/Follow Stiff @StiffArmWax on instagram here: https://www.instagram.com/stiffarmwax/
Dr. Deb Muth 00:04What if the future of healing isn’t about replacing cells, but about teaching your body how to heal itself again? We keep hearing the words stem cells and exoomes thrown around like they’re interchangeable, but they’re not. One is regulated, controversial, and often misunderstood. The other is rapidly emerging as one of the most exciting communication systems in human biology. Dr. Deb Muth 00:33And here’s the real question no one’s asking. Are we actually regenerating tissue or are we just stimulating the body to remember how it used to heal? Tired of being told your labs are normal, but you still feel terrible? At Serenity Healthcare Center, we don’t chase symptoms. We find the root cause. hormones, gut health, autoimmune conditions, chronic fatigue, brain fog. Dr. Deb Muth 01:02We use cuttingedge functional and regenerative medicine to get you real answers and a real path forward. This isn’t your average doctor’s office. This is medicine the way it was meant to be practiced. You deserve to feel like yourself again. Visit serenityhealthcarecenter.com to book your appointment today. Let us help you heal from the inside out. Dr. Deb Muth 01:28Welcome back to Let’s Talk Wellness Now. I’m Dr. Deb, your host. And if you’ve been following regenerative medicine, you’ve probably noticed the confusion. Patients are asking me every week, are exoomes stem cells? Are stem cells legal in the United States? I heard the FDA is shutting down all these clinics. Can I even get this therapy? Do I have to leave the country for treatment? Today, we’re cutting through the noise. This episode is not hype. Dr. Deb Muth 01:54It’s not sales. It’s education so you can understand the science, the regulatory reality, and the clinical difference between stem cell therapy and exoome therapy. And here’s what I want you to know right up front. Yes, these therapies are being used in the United States every single day. Yes, they’re being offered by highly trained physicians in integrative and regenerative medicine clinics across the country. Dr. Deb Muth 02:22Some are being used in FDA registered clinical trials. Some are being used in observational studies and some are being used in clinical practice under physician discretion. The landscape is nuanced and you deserve to understand it. So, grab your cup of coffee or tea and settle in for a deep dive into the most understood therapies in regenerative medicine. Dr. Deb Muth 02:43what they actually are, how they work, the regulatory landscape, and how they might support your body’s natural healing capacity. Let’s talk wellness now. So, let me start by asking you something. When you hear the word stem cell, what do you picture? Most people imagine damaged tissues magically regenerating or a torn meniscus growing back, cartilage reforming it into an arthritic joint or damaged brain tissue being replaced with healthy new beautiful cells. It’s a beautiful vision. Dr. Deb Muth 03:15And while it’s not quite that simple, the reality is actually more sophisticated and honestly more beautiful. Stem cells are powerful and they absolutely work, but the way they work and the mechanism by which they support healing is far more elegant and more so than most people really understand. And if you’re going to invest in regenerative therapy, you deserve to understand what you’re actually receiving. Dr. Deb Muth 03:44So, let’s start at the beginning. What are stem cells? At their core, stem cells are undifferentiated cells. That means they haven’t yet decided what they want to be when they grow up. Unlike a heart cell or a skin cell or a bone cell which have already committed to a specific function, stem cells exist in this beautiful state of potential. Dr. Deb Muth 04:05They have two remarkable abilities. First, they can self-renew. They can make copies of themselves, maintaining a reserve of these powerful cells throughout your lifetime. Second, they can differentiate under the right conditions. They can transform into specialized cell types. Bone cells, cartilage cells, nerve cells, muscle cells, even blood cells. Dr. Deb Muth 04:27This is why they’ve captured the imagination of the medical world. The potential is extraordinary. Now, there are several types of stem cells and understanding the differences matters tremendously for both understanding how they work and understanding how they’re regulated. Adult mezzenymal stem cells. We call these MSC’s are the most commonly used regenerative medicine. Dr. Deb Muth 04:54These come from bone marrow, atapost tissue, that’s fat, and other adult sources. They’re what we can call multi-potent, meaning they can become several types of cells, but not every type. A bone marrow stem cell isn’t going to become a brain cell, for instance. It has potential but it’s directed potential. Dr. Deb Muth 05:19Then we have perinatal stem cells. These come from umbilical cord blood cord tissue or something called Wharton’s jelly which is the gelatinous substance inside the umbilical cord. These cells are younger, more potent, and research by Weiss and colleagues published in stem cells back in 2006 showed that Wharton’s jelly derived MSC’s have superior proliferation and differentiation potential compared to bone marrow derived cells. Dr. Deb Muth 05:48They’re like comparing a 20-year-old athlete to a 50-year-old athlete. Both can perform, but one has more reserve capacity, more vigor, and more regenerative potential. And this isn’t this is very important because the perinatal sources umbilical cord tissue Wharton’s jelly amniotic tissue these are what many regenerative medicine clinics in the United States are using today and they’re using them because these tissues are incredibly rich in not just stem cells but growth factors cytoines and exoomes. Dr. Deb Muth 06:21Then there are embryionic stem cells. These are pur potent and they become any cell type in the body, but they’re highly regulated, ethically controversial, and honestly, they’re not being used in clinical practice in the United States outside of the very specific FDA approved research trials. Dr. Deb Muth 06:41So, when clinics talk about stem cell therapy, they’re almost never talking about embryionic stem cells. Now, here’s where it gets interesting and this is the part that changes everything about how we understand regenerative medicine. When you receive stem cell therapy, let’s say someone injects umbilical cord derived messenymal stem cells into your arthritic knee, those cells do not typically engraft or become new tissue in any permanent way. Dr. Deb Muth 07:12They don’t set up shop in your joint and start cracking out new cartilage cells for the rest of your life. So what are they actually doing then? Well, in 2011, researchers Arnold Arnold Kaplan and Dennis Korea published a landmark paper in stem cells translational medicine that fundamentally changed how we understand MSC therapy. Dr. Deb Muth 07:35They proposed that we should stop calling memal stem cells and start calling them medicinal signaling cells. Why? Well, because their primary therapeutic benefit doesn’t come from what they become. It comes from what they secrete. Think of stem cells as incredibly sophisticated biological pharmacies. When you inject them into damaged tissue, that arthritic knee, that inflamed autoimmune condition, that injured brain, that don’t just sit there passively, they sense the environment. Dr. Deb Muth 08:07They detect inflammation. They recognize the tissue damage and they understand that the immune dysregulation is present and they see that and respond. They start pumping out hundreds of bioactive molecules, growth factors that tell your cells to repair and rebuild, cytoines that modulate inflammation, chemocines that recruit your body’s own healing cells to the area. Dr. Deb Muth 08:32And these tiny membranes bound packages called extracellular vesicles, including exosomes, which we’re going to talk about extensively today as well. These secreted factors are giving instructions to your native cells. They’re saying, “Let’s reduce inflammation. Let’s modulate your immune response. Let’s promote angioenesis. Dr. Deb Muth 08:53” That’s the formation of new blood vessels, bringing nutrients and oxygen. Let’s stimulate your own resident stem cells to wake up and get to work. Reduce cell death in damaged tissue and restore normal cellular function. This is called paracrine signaling. It’s the cellto cell communication. And this is where the real therapeutic power lives. Dr. Deb Muth 09:14The stem cells themselves, many of them die within days to weeks, but the cascade of healing they trigger, the signals they send, the programs they activate in your own cells, those effects can last for months or even years. Now, this understanding is crucial because it explains why both stem cell therapy and exoo therapy can be effective. Dr. Deb Muth 09:38The stem cells are powerful not because they become new tissue but because of the signals they send and exoomes are those signals isolated and concentrated. The biggest misconception in regenerative medicine is that stem cells replace tissue and in reality they coach healing more than they become healing. They’re biological educators teaching your body to remember how it used to heal before chronic inflammation, toxicity, and disease turned off all those programs. Dr. Deb Muth 10:12So if stem cells don’t exactly end graft and become the new tissue, if their power is in their signaling and then next logical question is why do we need the cells at all? Well, if we could isolate the messengers themselves, what if we could deliver just the communication systems without any of the complexity of the living cells? Well, that’s exactly what exosomes are. Dr. Deb Muth 10:38And they represent the cutting edge of regenerative medicine. So, let me paint you a picture of how cells actually communicate. Because for most medical history, we had it wrong. For decades, textbooks taught us that cells talk to each other in two basic ways. through direct contact like shaking hands or releasing signaling molecules that floated through the extracellular space like messages in bottles, simple chemical messages. Dr. Deb Muth 11:09But in the 1980s and 90s, researchers started discovering something far more sophisticated. cells were releasing these tiny membrane bound packages like a biological FedEx envelope kind of you know it was filled with complex specific cargo and these packages could travel through the blood cross the barriers that normally keep things out like bloodb brain barrier and deliver their contents to distant cells with remarkable precision. Dr. Deb Muth 11:38These are called extracellular vesicles. And exoomes are one of the most therapeutic important types. So what exactly are exosomes? Well, they’re nanosized vesicles, typically 30 to 150 nanome in diameter. To put that into perspective, a human hair is about 100,000 nanometers wide. These are incredible and most impossibly tiny. Dr. Deb Muth 12:09They’re released by virtually all cells in the body, but the most therapeutically interesting exoomes come from mezenymal stem cells. And those medicinal signaling cells we just discussed. And according to a landmark review of Raposo and Stervogal, they published in the journal of cell biology in 2013, exoomes are not cellular debris. They’re not waste products. Dr. Deb Muth 12:35They are precisely engineered communication vesicles or vehicles. Think of them as sophisticated delivery systems carefully packed, carefully labeled, and sent to specific destinations. very specific instructions. Inside each of these exoomes, you’ll find an incredibly sophisticated payload. They are microRNAs. These are small RNA molecules that can literally turn genes off or on in the recipient cells. Dr. Deb Muth 13:06They can tell a cell to start making more collagen, to reduce inflammatory proteins, to activate repair programs that have been shut down by chronic disease for a very long time. There are messenger RNAs, actual templates for protein production. And exoome can deliver these instructions for making healing proteins. There are proteins themselves, growth factors, cytoines, enzymes, all the molecular tools a cell needs to heal. Dr. Deb Muth 13:34And there are lipids, specialized fats that help the exoome membrane fuse with targeted cells, delivering the cargo inside. When an exoome reaches its target cell, it can either fuse the cell membrane and deliver its contents directly inside like a Trojan horse, or it can bind to surface receptors and trigger signaling cascades, setting off a chain reaction of healing responses. Dr. Deb Muth 14:01Either way, it’s delivering very specific targeted instruction. And here’s what makes this so powerful. Those instructions are tailored to what this recipient cell actually needs. So, let me give you some concrete examples of what the research actually shows because this is where it really gets exciting. When researchers inject MSC derived exoomes into hearts that had experienced eskeeia, reprofusion, injury, that’s damaged blood flow being cut off and then being restored. Dr. Deb Muth 14:36Kind of like what happens during a heart attack. Something remarkable happened. A study by Lei and colleagues published in stem cell research in 2010 showed that exoomes significantly reduced the size of the damaged area, reduced inflammatory cytoines that drive tissue destruction and promoted tissue repair signaling. The exoomes were telling the heart cells stop the inflammatory cascade, activate your survival programs and repair the damage. Dr. Deb Muth 15:06In cartilage research, tow and colleagues published work in biioaterials in 2017 showing that exosomes derived from MSC’s could promote cartilage regeneration in osteoarthritis models. And the exoomes carried specific microRNAs that told condondroytes cartilage cells to proliferate and make more extracellular matrix, the structural framework of healthy cartilage. Dr. Deb Muth 15:30for autoimmune conditions. Research by Blazic and colleagues in Frontiers in Immunology in 2014 demonstrated that MSC derived exoomes could shift immune cell behavior from pro pro-inflammatory to regulatory. They could take an overactive self-attacking immune system and restore balance and promote tolerance. And perhaps most exciting brain research, a study by Zinn and colleagues published in the journal of extracellular vesicles in 2013 showed that MSC derived exoomes could cross the bloodb brain barrier. Dr. Deb Muth 16:07That protective shield around your brain that normally keep things out and promote neurological recovery in stroke models. They reduced brain inflammation, promoted neuroplasticity, supported the formation of neural connections, and for mitochondrial dysfunction, which underlies so many chronic conditions, Morrison and colleagues published research and scientific reports in 2017 showing that MSC derived exoomes can actually deliver functional mitochondria or mitochondrial components to damaged cells. They’re not Dr. Deb Muth 16:40just sending instructions, they’re sending spare parts. They’re restoring the cellular powerhouses to produce energy. So why are exoomes fundamentally different from stem cells? Well, exoomes contain no living cells. They can’t replicate. They can’t end graph. And they have virtually no risk of immune rejection or tumor formation. Dr. Deb Muth 17:03Concerns that exist elevate rarely with cellular therapies. They’re essentially biological software updates for your cells. As Fineian Pitiger wrote in their seinal review in stem cells in 2017, MSC derived exoomes represent the active ingredient of stem cell therapy delivered in a cellfree format. That’s the key insight in the in the therapeutic benefit of stem cells and it comes from what they excrete. Dr. Deb Muth 17:33Then exoomes are the secretion isolated, concentrated, and standardized. From a practical clinical standpoint, exoomes offer several compelling advantages. First, consistency. Because exoomes can be isolated, characterized, and standardized, each dose can be remarkably consistent. With living stem cells, there’s variability based on donor age, health status, processing methods, and one batch may be robust, but another might be weaker. Dr. Deb Muth 18:05With exoomes, you can measure the content, measure the potency, and ensure the quality control. Second is storage. Exoomes can be liophalized. They can be freeze-dried and stored at room temperature or refrigerated for extended periods. Stem cells require cryopreserv preservation, careful freezing, careful thawing. They’re fragile. Dr. Deb Muth 18:31Exoomes are remarkably stable. And third, their safety profile. Without living cells, the risk of adverse imunological reactions is dramatically lower. You’re not introducing foreign cells that your immune system might recognize and attack. You’re introducing molecular messages. Fourth is scalability. You can harvest millions, even billions of exoomes from stem cell cultures without ever injecting the cells themselves. Dr. Deb Muth 19:01And you can produce large quantities, standardize them, and make them available to patients. Now, there is a caution here in doing this. The scalability can produce rogue cells, and we want to be cautious of that. So, here’s what I need you to understand. Exoomes don’t force healing. They remind the body how healing works. Dr. Deb Muth 19:24They’re not replacing damaged cells. They’re re-educating the cells you already have. They’re turning back time on the biological programs that got turned off by inflammation, toxicity, trauma, time, and chronic disease. Your body knows how to heal. It’s done its entire life. Every cut that closed, every bone that mended, every infection you fought off, your body orchestrated that healing. Dr. Deb Muth 19:51The problem is that chronic disease, chronic inflammation, toxic exposures, poor nutrition, stress, all of these things disrupt the communication networks that coordinate healing. And exoomes restore that communication. They’re like rebooting a computer that’s frozen. They reset the system and remind it how it’s supposed to function. All right. Dr. Deb Muth 20:14So, this would not be complete if we didn’t talk about regulation because this is where a lot of confusion exists. And I want you to be given a real picture. Not fear-mongering, not pretending. There aren’t regulatory considerations, but the actual practical reality of how regenerative medicine is practiced in the United States today. Dr. Deb Muth 20:38Here’s what you need to understand. The FDA regulates these therapies and they have specific frameworks, but there’s important nuances between regulatory text enforcement priorities and actual clinical practice. And there are also state level regulations that provide additional pathways. The FDA regulates human cells, tissues, and cellular and tissue based products. Dr. Deb Muth 21:05We call them HCT/PPS under two main pathways. Section 361 products are those that meet specific criteria. They’re minimally manipulated, intended for homologous use, meaning these tissues perform the same basic function in the recipient as it did in the donor. They’re not combined with non-tissue components and they’re either autotogus, meaning they come from your own tissue, or they have had minimal systemic effect. Dr. Deb Muth 21:38An example of a clear 361 procedure, your doctor harvests your own bone marrow, we call this PRP, performs minimally processing to or uh perform Yeah. performs minimal processing to concentrate the stem cells through a centriuge and injects it into your arthritic knee the same day. That’s autogus same day but minimally manipulated. Dr. Deb Muth 22:04This is unquestionably legal and is being done in regenerative medicine clinics across the country every single day. So there’s section 351 where products are those that don’t meet all the section 361 criteria. They’re classified as drugs or biologic products and they require FDA approval through clinical trials. Dr. Deb Muth 22:27Now here’s where this gets more nuanced. There are regenerative medicine clinics across the United States using stem cell and exoome therapies in different contexts. First FDA registered clinical trials. These are formal research studies with investigational new drug applications. Patients enroll in trials. They sign informed consents. Dr. Deb Muth 22:48They receive therapies as part of their structured research protocols. And this is completely legal and represents the gold standard for gathering evidence. Second is observational studies and registry programs. Many clinics are collecting systemic data on patient outcomes using these therapies even outside the FDA trials. Dr. Deb Muth 23:12They’re documenting results, tracking safety, and contributing to the growing body of clinical evidence. Third, there’s clinical practice under physician discretion. There are physicians using these therapies based on their own clinical judgment informed consent from patients and their interpretation of the regulatory framework particularly around minimal manipulation and homologous use. Dr. Deb Muth 23:34Now there are also state regulations that provide additional legal frameworks. So, for example, Florida has enacted the Right to Try Act and specific regenerative medicine legislation that allows physicians to offer certain stem cell therapies under the state oversight. Utah has passed similar legislation creating pathways for regenerative medicine products. Dr. Deb Muth 23:57And these state laws recognize that patients should have access to potentially beneficial therapies, particularly when used by trained physicians with appropriate informed consent. The regulatory question often centers around are these products minimally manipulated. Some products clearly are not. They’ve been cultured. Dr. Deb Muth 24:20They’ve been expanded in laboratories and those require FDA approval that they don’t have. The FDA has appropriately shut down clinics using those products. But there are other products that undergo processing that many physicians and manufacturers argue constitutes minimal manipulation. And these tissues are cleared, potentially fragmented or particulated to make them more suitable for injection, preserved using methods like cryopreservation or liophalization and packaged. Dr. Deb Muth 24:54But the cells are not cultured or expanded in the laboratory. The FDA has issued guidance suggesting that many of these processing steps constitute more than manipul minimal manipulation. But many physicians, particularly those who specialized in regenerative medicine for years, disagree with that interpretation and they believe that the processing qualifies as minimal manipulation and that the product should fall under section 361 when used for homologous purposes. Dr. Deb Muth 25:24Is there regulatory debate? Absolutely. The FDA and some clinicians have different interpretations of what constitutes minimal manipulation. But here’s the practical reality. There are hundreds of well-trained, bore certified physicians across the United States offering these therapies every single day. Dr. Deb Muth 25:42They’re doing so based on their understanding of the regulations, their clinical experience, their commitment to patient safety, and their belief that these therapies can help people who have exhausted conventional options. The FDA’s enforcement priorities have focused primarily on the most problematic cases. Clin clinics making blatant disease cure claims, products with documented safety issues, clear cases of cellular expansion and culture, or clinics operating with no medical oversight. Dr. Deb Muth 26:15Reputable regenerative medicine physicians are using products from companies that provide comprehensive documentation of their processing methods. third-party sterility testing, certificates of analysis showing bioactive content, and quality control measures that meet or exceed industry standards. Now, let me be very clear about something. Dr. Deb Muth 26:36Quality matters enormously. Not all stem cells and exoome products are created equal. Research by Burger and colleagues published in the Orthopedic Journal of Sports Medicine in 2021 analyzed 12 commercially available stem cell products and found that many contained zero viable cells, high levels of bacteria, endotoxins and inconsistent growth factor concentrations. Dr. Deb Muth 27:01This is why the company providing these biologic matters tremendously. You want products from manufacturers who provide transport documentation in sourcing and processing. Conduct third-party testing and sterility and potency. Offer certificates of analysis for each batch. Use standardized validated processing protocols. Dr. Deb Muth 27:24Have quality control measures that ensure consistency and don’t make outrageous cure claims or promise. The best regenerative medicine physician carefully vet their suppliers. They don’t use products from companies making unrealistic promises. They use products from manufacturers who are transparent, scientifically rigorous, and committed to quality. Dr. Deb Muth 27:46Now, you specifically ask about homologous use and collagen defects. So, let me address this directly for you. Under the FDA guidance, homologous use means the tissue performs the same basic function in the recipient as in the donor. So for connective tissue, tendons, ligaments, cartilage, fascia, all of that which are collagenrich structures using MSC’s or their derivatives could be considered homologous use. Dr. Deb Muth 28:17MSC’s in their native environment provide structural support to produce extracellular matrix including collagen. Using them to support healing in damaged collagen rich tissues like arthritic joints, torn tendons or degenerative ligaments is arguably the same basic function. So using exoomes derived from MSC’s to support collagen synthesis reduce inflammation and promote tissue healing in the same structures. Dr. Deb Muth 28:46Many practitioners argue this also qualifies as homologous use because you’re supporting the structure and function that MSC’s would naturally support. So here’s the bottom line on the regulatory reality. Regenerative medicine is available in the United States. It’s being offered by highly trained physicians in integrative and regenerative medicine clinics across the country. Dr. Deb Muth 29:11Some therapies are offered in FDA registered clinics and some are offered in observational studies. Some are offered in clinical practice under physician discretion, informed consent, and careful attention to safety. The regulatory landscape is evolving. There are ongoing discussions both federally and state levels about creating clearer pathways for these therapies. Dr. Deb Muth 29:32So, if you choose to go down this road, you want to work with physicians who understand the regulations, who use quality products from reputable manufacturers with rigorous testing and documentation, who are transparent about what they’re using and why, who discuss the current regulatory landscape honestly with you, and who prioritize your safety and truly informed consent above all else. Dr. Deb Muth 29:55This is not a lawless wild wild west. But it is also not as simple as everything is legal and unavailable. It’s a nuanced landscape that requires ethical knowledge. And these practitioners that have this knowledge have got to provide informed patients who understand both the potential benefits and the current regulatory context. Dr. Deb Muth 30:17So let’s have some fun here. Let’s talk about what really matters to you that are listening and that’s what conditions are being supported with these therapies. What does the research show and what are clinicians seeing in actual practice with patients? Because here’s what’s really important. We have both published research evidence and extensive clinical experience. Dr. Deb Muth 30:38And when the two align, that’s when we can feel confident and comfortable about using these approaches. So, let’s start where we have the most substantial evidence. joint health and muscularkeeletal conditions. For arthritis, we have good data. A systemic review by Tan and colleagues published in arthritis research and therapy in 2021 analyzed 20 randomized controlled trials in MSC therapy for knee osteoarthritis. Dr. Deb Muth 31:05They found significant improvements in pain and function particularly in mild to moderate disease. What’s really interesting is when researchers start analyzing whether it was the cells themselves or their secreted factors doing the work. They found that exoomeenriched preparations showed similar benefits to whole cell therapy. Dr. Deb Muth 31:26Now towen colleagues in the biioaterials paper from 2017 demonstrated that MSC derived exoomes could promote cartilage matrix synthesize and reduce inflammation markers. The exoomes carried microarnas that told cartilage cells to make more collagen and proteoglycans, the building blocks of healthy cartilage. Dr. Deb Muth 31:49In clinical practice, physicians are seeing patients with knee, hip, shoulder, and spinal arthritis, experiencing reduced pain, improved function, better motility, and in some cases, measurable improvements in their tissue. I want to share a story here with you because back in 2006, my husband was injured at work. Some of you might have heard me tell this story before. Dr. Deb Muth 32:11Um, he broke two discs in his back and underwent surgery very early on when we started using stem cells. They had put cages and plates in and they used MSC’s to put inside the cage to create a hardened bone so that he could have a fusion and hopefully not have any pain. At the time, what the physician didn’t realize or mistakenly did was he did not put any human bone mixed with these dead cadaavver bone MSC’s. Dr. Deb Muth 32:42And so the MSC’s never grew. They didn’t have anything to grow by. So the plates and the screws just kind of went back and forth for six months before he could see another physician that would look at him differently and understand what actually happened. That was very early on. Today we know so much more than we did before. Dr. Deb Muth 33:01Fast forward to 2014 when my husband was having problems and he couldn’t feel his legs, he couldn’t feel his feet. We decided to undergo uh exoo and stem cell therapy again and we saw a physician in Florida who harvested cells from his bone marrow and his blood and his fat and mixed that all together and then put that back into the back. Dr. Deb Muth 33:27and he had tremendous benefit from it. So, I tell this story because I want you to see the trajectory of how long this has been going on that we’ve been using this and we’re learning as we’re going and things are changing rapidly in this in this world. And so, what we know today and what I’m teaching you today may very well change in a month or six months or a year from now, but we have the foundation at least to understand what is helpful, what is not right now. Dr. Deb Muth 33:54But just be aware that if you’re embarking on exoome or stem cell therapy or MSC’s that you understand that this terrain is going to change. So back to my conversation about what other things can we treat? Well, we can treat tendon and ligament injuries, chronic tennis elbow, Achilles tendonopathy, rotator cuff tears, chronic planter fasciitis. Dr. Deb Muth 34:17These were researched by PA and colleagues in the American Journal of Sports Medicine in 2017 and it showed that bone marrow concentrate injections resulted in improved pain and function compared to steroid injections. Now this mechanism appears to be enhanced collagen remodeling and reduced chronic inflammation. Dr. Deb Muth 34:39These are structural collagenrich tissues using MSC’s or their derivatives for structural support which makes biological sense. It’s homologous use. It’s similar. So clinically we’re seeing athletes, active adults and people with chronic pain who failed physically um failed physical therapy, failed conservative treatments finding relief in this functional uh improvement in this functional world that we live in today. Dr. Deb Muth 35:07So, I want to be clear about what we’re doing here for joint and muscularkeeletal issues. We’re not growing completely new cartilage from scratch or severely destroyed joints. We’re not magically regenerating tissues that’s been gone for decades. That’s not possible here. What you’re doing when you’re using MSSE’s and exoomes is supporting the body’s natural ability to repair, reducing inflam inflammation and damage, and we’re driving progressive degeneration uh or we’re stopping the progressive degeneration. By reducing the Dr. Deb Muth 35:41inflammatory damage, we’re stimulating resonant stem cells that have been dormant. We’re improving blood flow and uh uh oxygen to the tissues like cartilage and tendons. and we’re organizing the body to start creating its own quality collagen as it heals. So, it’s a regenerative support, not a tissue replacement. Dr. Deb Muth 36:07But for many people, this support is lifechanging. So, let’s talk about autoimmune disorders now because this is one of the most exciting and unrecognized applications. autoimmune conditions like rheumatoid arthritis, lupus, MS, Crohn’s disease, ulcerative colitis, Hashimoto’s, they all involve the immune system and the immune system is deregulated. Dr. Deb Muth 36:30And so basically your immune system is seeing this tissue as foreign and it’s attacking it. These MSC’s and their exoomes have profound immune modulatory properties. They don’t suppress the immune system like steroids or imunosuppressive drugs. They modulate it helping to restore balance. So for rheumatoid arthritis, research by Weang and colleagues in stem cells translational medicine in 2016 showed that MSC derived exoomes could shift the balance of immune cells, reducing pro-inflammatory TH7 cells that drive joint disruption uh and increase Dr. Deb Muth 37:08regulatory TE-C cells that maintain immune tolerance. So for MS, a clinical trial by Kasus and colleagues published in archives of neurology back in 2010 evaluated autotogus MSC therapy and MS patients and they found evidence of reduced disease activity, improved neurological function and decreased inflammatory uh lesions on MRI scans. Dr. Deb Muth 37:34The proposed mechanism is MSC’s and their exoomes reduce inflammatory cytoine production promote regulatory imu immune populations support remination of damaged nerves that is rebuilding the protective coating around the nerve fibers and it reduces bloodb brain barrier permeability which prevents immune cells from attacking their brain and spinal cord. Dr. Deb Muth 38:02And so for inflammatory bowel disease, the research by Barnholm uh sorry Barnhorn and colleagues in gut in 2020 showed that MS cell MSC derived extracellular vesicles could support mucosal healing and reduce inflammation in the gut lining. They appeared to restore intestinal barrier function, healing that leaky gut and modulating local immune responses. Dr. Deb Muth 38:30So in clinical practice, physicians are seeing patients with autoimmune conditions, experiencing reduced disease flares, decreasing the need for imunosuppressive medications, improving energy and quality of life, and in some cases extending periods of remission. But here’s what I want you to understand. Dr. Deb Muth 38:52When you see these therapies for autoimmune conditions, we are supporting immune regulation and reducing inflammatory damage. We are not treating or curing the disease in a conventional sense. These therapies work best as part of a comprehensive functional medicine approach that also addresses gut health because 70% of your immune system lives in your gut and environmental triggers like mold, heavy metals, chemical toxins that can drive autoimmune responses, chronic infections that can trigger immune disregulation, stress and nervous system imbalance. And Dr. Deb Muth 39:29these nutritional deficiencies are necessary to help improve the immune function. So regenerative therapy without addressing root causes is like bailing water out of your boat without plugging the hole. You might get temporary relief, but the underlying problem still remains. So let’s talk about neurological conditions. Dr. Deb Muth 39:52And this is where the science gets truly fascinating. for traumatic brain injury and concussion. Research by Zang and colleagues in the Journal of Neurot Trauma in 2015 showed that MSC derived exoomes could reduce brain inflammation, promote neuroplasticity, that’s the brain’s ability to rewire itself and improve cognitive outcomes in animal models. Dr. Deb Muth 40:17The exoomes crossed the bloodb brain barrier, delivered neuroprotective proteins and microRNAs. They reduced inflammation, supported mitochondrial function in injured neurons and promoted both new blood vessels from new blood formation and neurogenesis and the birth of new neurons occurred. Neurological recovery requires a multi-systematic approach. Dr. Deb Muth 40:42Exoomes may support neural repair, but they work best combined with hormone optimization, growth hormone, testosterone, thyroid, pregnnolone, mitochondrial support compounds like NAD, CoQ10, PQQ, carnitine, all of those things that we use traditionally in functional medicine. Now for stroke recovery, there was research by Zinn and colleagues in the journal of extracellular vesicles that showed MSC derived exoomes reduced the size of brain damage and improved neurological recovery in animal models. There was a Dr. Deb Muth 41:19Parkinson’s disease study done by Kimoji and colleagues in the movement disorders in 2018 that suggested that MSSE derived exoomes could support dopamineergic neuron survival and those are the cells that die in Parkinson’s and it can help to reduce neuroinflammation. Clinically, physicians are seeing improvements in patients with postconussion syndrome, chronic traumatic brain injury, early stage cognitive decline, and other neurodeenerative conditions. Dr. Deb Muth 41:52These are not cures, but meaningful improvements in cognitive function, mood, energy, and quality of life. Now, let’s talk about autism spectrum disorder very carefully here because this is a very sensitive but very important topic for families. There have been several clinical trials that have explored MSC therapy for autism. Dr. Deb Muth 42:16Liv and colleagues published research in stem cell translational medicine in 2013 showing improvements in social interaction, communication, and behavioral symptoms in children with ASD who received cord blood MSC’s. Dawson and colleagues in 2017 conducted randomized trial autotogus cord blood infusion and found modest improvements in social communication particularly in children with higher baseline immune dysregulation. Dr. Deb Muth 42:47The proposed mechanisms for modulation of neuroinflammation support the mitochondrial function because many children with autism show evidence of mitochondrial dysfunction, reduction of oxidative stress, improvement in gut brain access dysfunction and modulation of immune dysregulation. In clinical practice, some physicians are seeing improvements in some children, better eye contact, increased language development, reduced sensory sensitivities, improved social engagement, but responses vary significantly, and we cannot predict which children will benefit most. So for Dr. Deb Muth 43:26families considering regenerative approaches for autism, these therapies are supporting the body’s healing mechanisms, reducing neuroinflammation, supporting cellular energy production, modulating immune function. These should only be considered as part of a comprehensive biomedical approach that includes dietary interventions to address food sensitivities, support gut health, environmental toxin removal, particularly heavy metals and chemical exposures, gut healing protocols with targeted probiotics and nutrients, Dr. Deb Muth 44:00metabolic testing and targeted supplementation, and evidence-based on behavioral and developmental therapies. These therapies should only be pursued with practitioners who are honest about what we know and what we don’t know and who follow rigorous safety protocols who never promise cures and who view regenerative medicine as a tool in the comprehensive healing strategy, not a standalone miracle. Dr. Deb Muth 44:26Not only that, these therapies will most likely need to be given several times over the course of this person’s lifetime, possibly even on an annual basis. And this is really important because it is not a oneandone. It is not a one-sizefits-all, and it needs to be looked at as a long-term option for working with autism. So, since we’re looking at stem cells versus exoomes, living cells, with stem cell therapy, you’re receiving living cells that can survive in your body for days to weeks. Dr. Deb Muth 45:02With exoome therapy, there are no living cells, just biological messages they would have sent. So, replication stem cells can potentially replicate. Although therapeutically this happens minimally, exoomes cannot replicate. They deliver the cargo and then they are cleared by your body. With stem cells, it’s primarily paracrine signaling. Dr. Deb Muth 45:28They’re coaching your cells to heal. With exoomes, it’s pure signaling, pure reprogramming your cells without any cellular component. Stem cells as we talked about can be autotogus from your own bone fat, blood or um bone marrow or allergenic from umbilical cord tissue or Wharton’s jelly. Dr. Deb Muth 45:50Exoomes are typically derived from cultured MSC’s often from umbilical cord or bone marrow sources and both can be given by local injection for targeted treatment of joints and tissues and exoomes can be given intravenously for whole body systemic support. both have um low immun immunogicity. I can’t say that word today. Dr. Deb Muth 46:17But exoomes have even lower risk since they contain no cellular material. Now, it’s absolutely critical for you to understand that there are massive quality differences. We’ve talked about this earlier. I want you to be very aware of this and have a conversation with any of the practitioners that you’re considering undergoing this treatment with. Dr. Deb Muth 46:37Here is where it matters more than anything when you’re considering regenerative medicine, the quality of the products and the expertise of the practitioner. Because the reality is not all regenerative medicine products are created equal. We all know that when we take different supplements and not all practitioners understand these therapies at the same depth. Dr. Deb Muth 46:58You want to look for practitioners that are board certified or have some kind of specialized regenerative medicine training. You want to know their clinical experience. How much have they done these procedures? How long have they done this? You want honest communication about the evidence and the limitations in this. Dr. Deb Muth 47:17You want a comprehensive functional medicine approach to go along with these therapies. And you want somebody that’s transparent about their informed consent and their regulatory status. If you have people that are uh claiming that they can cure disease or giving you guarantees, that is not that is not a good practitioner to work with. Dr. Deb Muth 47:37If you have high pressure sales tactics, you need to decide today limited supply for a week. These are marketing manipulations. It’s not medical care. You want to be cautious of extremely low prices because quality regenerative products are expensive to source, process, and test. and store. And if somebody’s offering stem cells or exoomes for a few hundred dollars, seriously, you need to question the quality, the safety, and where they got this from. Dr. Deb Muth 48:09So before undergoing any regenerative therapy, make sure you’re having a very, very lengthy conversation with the person and so you truly understand exactly what you’re getting, how it’s going to be delivered, and what they’re going to do. If there’s one thing I want you to take away from today is that your body has remarkable capacity to heal when given the right biological signals and the right environment. Dr. Deb Muth 48:35Stem cells and exoomes are powerful tools for providing biological signaling that can reduce inflammation, modulate immune function, support tissue repair, and restore cellular communication that’s been disrupted by chronic disease and inflammation. These therapies are available in the United States through trained physicians working in FDA registered trials, observational studies, and clinical practice, and using quality products from manufacturers with rigorous testing and quality control. Dr. Deb Muth 49:04So before you invest in regenerative medicine, do your homework. Ask detailed questions about product quality and source. Verify the products come from reputable manufacturers with certificates of analysis, third-party testing. Work with experienced practitioners. And remember, no injection, no infusion, no biologic can overcome ongoing toxic exposure, chronic stress, poor nutrition, gut dysfunction, and inadequate sleep. Dr. Deb Muth 49:34True healing requires your body and you to actively participate in this healing. If you are unwilling to address the root causes and change the lifestyle factors that disrupted your health in the first place, the biologics can amplify your healing signals, but you have to create the internal environment where healing can actually happen. Dr. Deb Muth 49:56So, I hope this episode has helped you understand regenerative medicine more clearly. Share it with somebody who’s looking for healing beyond the conventional approaches. And until next time, this has been Let’s Talk Wellness Now. Have a blessed day. >> Welcome to Let’s Talk Wellness Now, where we bring expert insights directly to you. Dr. Deb Muth 50:16Please note that the views and information shared by our guests are their own and do not necessarily reflect those of Let’s Talk Wellness Now, its management, or our partners. Each affiliate, sponsor, and partner is an independent entity with its own perspectives. Today’s content is provided forformational and educational purposes only and should not be considered specific advice, whether financial, medical, or legal. Dr. Deb Muth 50:41While we strive to present accurate and useful information, we cannot guarantee its completeness or relevance to your unique circumstances. We encourage you to consult with a qualified professional to address your individual needs. Your use of information from this broadcast is entirely at your own risk. Dr. Deb Muth 51:00By continuing to listen, you agree to indemnify and hold Let’s Talk Wellness Now and its associates harmless from any claims or damages arising from the use of this content. We may update this disclaimer at any time, and changes will take effect immediately upon posting or broadcast. Thank you for tuning in. We hope you find this episode both insightful and thought-provoking. Listener discretion is advised.The post Episode 265 – The Future of Healing: How Exosomes Re-Educate Your Body to Heal Itself first appeared on Let's Talk Wellness Now.
In this episode, hosts Ray Powell and Jim Carouso sit down with retired U.S. Ambassador to the Philippines MaryKay Carlson, who led America's embassy in Manila from July 2022 to January 2026, one of the most consequential periods in the modern history of the U.S.-Philippine alliance.Ambassador Carlson takes us inside the alliance at a moment of dramatic transformation: the 75th anniversary of the U.S.-Philippines Mutual Defense Treaty, the 80th anniversary of diplomatic relations, the 10th anniversary of the 2016 Arbitral Award on the South China Sea, and the Philippines' year as ASEAN Chair under President Ferdinand “Bongbong” Marcos Jr.. She walks us through the most dangerous flashpoints in the West Philippine Sea: the June 2024 ramming at Second Thomas Shoal (Ayungin) that cost a Filipino sailor his thumb, and the August 2025 Scarborough Shoal incident in which a Chinese Coast Guard cutter collided with its own PLA Navy destroyer while chasing a Philippine vessel.We dig into the strategic geography that makes the Philippines irreplaceable to America's Indo-Pacific strategy; the largest Balikatan exercise in history; the expansion of EDCA sites; the new $2.5 billion Philippine Enhanced Resilience Act; the new Luzon Economic Corridor (with Japan); the U.S.-Philippines 123 civil nuclear agreement; and the 19% Trump tariff Carlson openly wishes had been much lower. She offers a candid read on China's Ambassador Huang Xilian's successor, Jing Quan, the limits of the ASEAN Code of Conduct, and what actually deters Beijing's gray-zone aggression in the South China Sea.If you follow U.S.-China competition, the U.S.-Philippines alliance, ASEAN, Philippine politics, the Marcos administration, Indo-Pacific strategy, the South China Sea, or U.S. foreign policy under the second Trump administration, this is essential listening from someone who lived it up close.
Josh (@cardboard_chronicles) and Chris (@chris_hoj), the founders of Card Ladder, join forces to bring you the most entertaining and educational sports card discussion on the internet every Friday night.Conduct your own Card research like the pro's with Card Ladder. Go to http://www.cardladder.com and browse thousands of cards for free and you can unlock more great features by going pro for $15/month (with a 7-day free trial).Follow Card Ladder @CardLadder on instagram here: https://www.instagram.com/cardladder/Follow Josh @Carboard_Chronicles on instagram here: https://www.instagram.com/cardboard_chronicles/Follow Chris @Chris_HOJ on instagram here: https://www.instagram.com/chris_hoj/Follow Kristina @KristinasPC on instagram here: https://www.instagram.com/kristinaspc/Follow Stiff @StiffArmWax on instagram here: https://www.instagram.com/stiffarmwax/
© 2020-2026 Ivy Podcast Discovery LLC
